Alcoholic Intoxication, Chronic
|
0.310 |
Biomarker
|
disease |
PSYGENET |
We found seven significant associations between CAMK2A SNPs and alcohol dependence, one of which in an autophosphorylation-related area of the gene.
|
23459588 |
2013 |
Cocaine Dependence
|
0.310 |
Biomarker
|
disease |
CTD_human |
Suppressing calcium/calmodulin-dependent protein kinase II activity in the ventral tegmental area enhances the acute behavioural response to cocaine but attenuates the initiation of cocaine-induced behavioural sensitization in rats.
|
14725635 |
2004 |
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 63
|
0.300 |
GeneticVariation
|
disease |
UNIPROT |
A homozygous loss-of-function CAMK2A mutation causes growth delay, frequent seizures and severe intellectual disability.
|
29784083 |
2018 |
Hepatomegaly
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Discriminating between adaptive and carcinogenic liver hypertrophy in rat studies using logistic ridge regression analysis of toxicogenomic data: The mode of action and predictive models.
|
28108177 |
2017 |
Hepatolenticular Degeneration
|
0.300 |
Biomarker
|
disease |
CTD_human |
The early molecular processes underlying the neurological manifestations of an animal model of Wilson's disease.
|
23519153 |
2013 |
Hepatic Form of Wilson Disease
|
0.300 |
Biomarker
|
disease |
CTD_human |
The early molecular processes underlying the neurological manifestations of an animal model of Wilson's disease.
|
23519153 |
2013 |
Allodynia
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Ca2+/calmodulin-dependent protein kinase II alpha is required for the initiation and maintenance of opioid-induced hyperalgesia.
|
20053885 |
2010 |
Hyperalgesia, Primary
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Ca2+/calmodulin-dependent protein kinase II alpha is required for the initiation and maintenance of opioid-induced hyperalgesia.
|
20053885 |
2010 |
Hyperalgesia, Secondary
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Ca2+/calmodulin-dependent protein kinase II alpha is required for the initiation and maintenance of opioid-induced hyperalgesia.
|
20053885 |
2010 |
Tactile Allodynia
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Ca2+/calmodulin-dependent protein kinase II alpha is required for the initiation and maintenance of opioid-induced hyperalgesia.
|
20053885 |
2010 |
Hyperalgesia, Thermal
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Ca2+/calmodulin-dependent protein kinase II alpha is required for the initiation and maintenance of opioid-induced hyperalgesia.
|
20053885 |
2010 |
Mechanical Allodynia
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Ca2+/calmodulin-dependent protein kinase II alpha is required for the initiation and maintenance of opioid-induced hyperalgesia.
|
20053885 |
2010 |
Unipolar Depression
|
0.300 |
Biomarker
|
disease |
PSYGENET |
As a result, 99 genes were listed as the differentially expressed genes in major depression, of which several genes such as FGFR1, NCAM1, and CAMK2A were of interest.
|
18068248 |
2008 |
Major Depressive Disorder
|
0.300 |
Biomarker
|
disease |
PSYGENET |
As a result, 99 genes were listed as the differentially expressed genes in major depression, of which several genes such as FGFR1, NCAM1, and CAMK2A were of interest.
|
18068248 |
2008 |
Cocaine Abuse
|
0.300 |
Biomarker
|
disease |
CTD_human |
Suppressing calcium/calmodulin-dependent protein kinase II activity in the ventral tegmental area enhances the acute behavioural response to cocaine but attenuates the initiation of cocaine-induced behavioural sensitization in rats.
|
14725635 |
2004 |
Cocaine-Related Disorders
|
0.300 |
Biomarker
|
group |
CTD_human |
Suppressing calcium/calmodulin-dependent protein kinase II activity in the ventral tegmental area enhances the acute behavioural response to cocaine but attenuates the initiation of cocaine-induced behavioural sensitization in rats.
|
14725635 |
2004 |
Autism Spectrum Disorders
|
0.210 |
GeneticVariation
|
disease |
BEFREE |
At the phenotypic level, we nominally replicated associations of CAMK2A-rs2241694 with non-verbal communication in both combined LIQ and HIQ ASD cohorts.
|
29147782 |
2018 |
Autism Spectrum Disorders
|
0.210 |
Biomarker
|
disease |
MGD |
|
|
|
Infarction, Middle Cerebral Artery
|
0.200 |
Biomarker
|
disease |
RGD |
Protein kinase C-gamma and calcium/calmodulin-dependent protein kinase II-alpha are persistently translocated to cell membranes of the rat brain during and after middle cerebral artery occlusion.
|
14688616 |
2004 |
Transient Ischemic Attack
|
0.200 |
Biomarker
|
disease |
RGD |
Cerebral ischemia immediately increases serine phosphorylation of the synaptic RAS-GTPase activating protein SynGAP by calcium/calmodulin-dependent protein kinase II alpha in hippocampus of rats.
|
12951199 |
2003 |
Inflammation
|
0.200 |
Biomarker
|
phenotype |
RGD |
Localization of CaMKIIalpha in rat primary sensory neurons: increase in inflammation.
|
12176168 |
2002 |
Depression, Bipolar
|
0.200 |
Biomarker
|
disease |
MGD |
|
|
|
Manic Disorder
|
0.200 |
Biomarker
|
disease |
MGD |
|
|
|
Mixed bipolar I disorder
|
0.200 |
Biomarker
|
disease |
MGD |
|
|
|
Ulcerative Colitis
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Genome-wide association study implicates immune activation of multiple integrin genes in inflammatory bowel disease.
|
28067908 |
2017 |